LCN2 and Alzheimer disease: In cohort 4, VaD (n = 10) displayed higher LCN2 concentrations than AD (n = 28), SVDND (n = 3), and VCIND (n = 8), although significant differences were only detected between AD and VaD groups (p < 0.05) (Supplementary Table 1, Fig. 3b).